What About Health 3: Challenging Behaviors

Size: px
Start display at page:

Download "What About Health 3: Challenging Behaviors"

Transcription

1 The title of this presentation is What About Health. I m. In this presentation I will discuss a number of health and mental health issues related to children with ASD. 1

2 Now I am going to switch to discussing challenging behaviors in children with ASD and then finally the use of psychotropic medications. This slide lists a number of different behaviors tahat can be problematic in children with ASD. Some children may meet criteria for other mental health disorders such as ADHD, anxiety disorders and depression or mood disorders. Please note: some of these behaviors may have an adaptive function for the child. For example, repetitive behavior, routines and even self-stimulatory behavior may help a child with ASD and anxiety cope with a given situation. 2

3 This slide describes an overall approach to understanding challenging behaviors in children with ASD. Any behavior is a form of communication. For example, a child who pushes school material off the desk and throws a tantrum is likely communicating the work is frustrating or too difficult and I need a break. It is always important to rule out any possible medical cause such as pain from an absessed tooth or GERD. Autism specific issues may make challenging behavior more likely. For example, (rest as per slide) 3

4 The first approach to understanding and treating challenging behaviors is to understand the function of the behavior. An excellent way to understand and interpret a specific behavior is by determining the function of that behavior. The ABC s of behavior is a method parents and professionals can use to analyze the function of a behavior. (rest as per slide) 4

5 Once the function of a behavior is understood, changing the context in which the behavior occurs may be the only treatment necessary. This is called providing positive behavioral supports. Conside communication needs.. (rest as per slide) 5

6 Now I weill briefly discuss the use of psychotropic medications in children with ASD. Why are they used? (rest as per slide) 6

7 In the past there has been limited research on the efficacy of medications in children with ASD. Fortunately this is changing with development of the Autism Network of Research Units on Pediatric Psychopharmacology (RUPP). Another resource is the Autism Treatment Network s Autism Intervention Research Network on Physical Health (AIR-P). 12 universities are participating, OHSU is no longer a participant. When using any psychotropic medication it is important to remember.. (rest as per slide) 7

8 Before prescribing any medication make sure you have ruled out possible medical causes for the challenging behaviors and then think about the ABC s of behavior and any contextual factors that might be changed. This is particularly important for children with aggression and self-injurious behaviors. Then.. (reat as per the slide) 8

9 This slide presents the different classes of medications that may be helpful in the treatment of specific behaviors in children with ASD. Following each class of medications is a brief list of possible indications. Please revie the slide 9

10 This slide lists the possible side effects of the different groups of medications. Please review the slide. *Serotonin syndrome is characterized by agitation, confusion, sweating and shivering, headache, rapid heart rate, muscle twitching, tremor, possible seizures and unconsciousness You will need to follow weight gain and cholesterol/lipid studies regularly in children who take atypical neuroleptics. Increased appetite and weight gain are greater problems with some (e.g., risperidone) than others (e.g., aripiprazole). There is a Black Box warning for anti-depressants (SSRI s and Atomoxetine) regrading the increased risk of suicide in treatment of adolescent depression. 10

11 Stimulants are the first choice for treatment of hyperactivity and ADHD in children with asd. In general they are somewhat less effective than in typically developing children with ADHD and children with ASD and no intellectual impairment are more likely to respond. (rest as per slide) RCT of extended release guanfacine by RUPP, 2015 Atomoxetine modest benefit, may cause activation in bipolar disorder. Resource: ATN ASD and ADHD guidelines, first stimulant, 2nd stimulant, 3rd alpha agonist or norepinephrine reuptake inhibitor, then atypical (reserve fro severe dysfunction) Stimulant side effects include agitation, irritability, dysphoria, loss of appetite, weihgt loss, and sleep problems Adrenergic agonist side effects include sedation, headache, nausea, hypotension (rare), rebound hypertension if D/Ced quickly. Atomoxetine side effects include sedation, decreased appetite, nausea and vomiting, dizziness, syncope, mood swings, possible liver toxicity also possible increased suicide risk if co-occurring depression Atypical side effects include weight gain, sedation, hyperglycemia, hyperlipidemia, prolactin elevation, occasionally extra-pyramidal, rarely neuroleptic malignant syndrome. Need to monitor blood glucose, lipids and BMI 11

12 When treating aggression it is particularly important to conduct a functional analysis first, i.e., the ABC s of challenging behaviors! Typical neuroleptics are not used due to the high risk of side effects when compared to the newer atypical neuroleptics medications such as risperidone and aripiprazole. There is limited support for use of anticonvulsants for irritability/mood disorders in children with ASD. (rest as per slide) 12

13 The combination of medication and behavioral treatments con be effective. For example, this study compared risperidone alone with risperidone combined with parent training,,,,,,,, (rest as per slide) The differences, however, attenuated at the 1 year follow-up. Most children were still on medication and some on additional medications. The parents in combined treatment more likely to seek behavioral supports (additional parent training) 13

14 Cognitive behavioral therapy CGT) can be effective in adolescents without intellectual disability. Limited data supprts the combination of CBT and medication is more effective than either alone in the treatment of anxiety disorders in typically developing children. Limited data supports the use of SSRI s to teat anxiety in children with ASD. They are more likely to be effective with children who occurring anxiety disorder (rest as per slide) 14

15 A great deal of current research is focused on medications that address a specific pathogenetic mechanism. For example, children with ADHD who have the DRT 4 gene variant are much more likely to respond to psychostimulants. Minocycline addresses a specific genetic mechanism in Fragile X syndrome, it inhibits MMP9 gene function. Similarly medications that address the dysregulation of the glutaminergic system are being tried in children with ASD or Fragile X. (review the list). And lastly, oxytocin also known as the social hormone is being studied in children with ASD. Studies have reported mixed results, however, with several reporting significant positive change in autistic behaviors. 15

16 S slide lists behavioral resources for parents and professionals. The Problem Behavior Manual is a guide for parents to conduct their own functional analysis of challenging behaviors using the ABC s method. 16

17 Here are some resurces on medications, their uses and side effects. The tool kit developed by the AIR-P is an excellent resource for families. It includes questions to ask before starting a new medication, a discussion of monitoring and managing side effects, a table on medications that may be helpful and their indications and side effects, tips on teaching kids to take pills, a medication log and a behavioral log to help parents in following the benefits of a medication. Medline Plus is not written specifically for children but includes a great deal of information on specific medications and supplements. 17

18 18

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral

More information

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder Cynthia King, MD Associate Professor of Psychiatry UNMSOM Autism Spectrum Disorder 1 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive

More information

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM Cynthia King, MD Associate Professor of Psychiatry UNMSOM 1 2 Autism Spectrum Disorder 3 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive

More information

Challenging ASD Cases November 11, Melanie Penner, MD, MSc, Mohammad Zubairi, MD, MEd,

Challenging ASD Cases November 11, Melanie Penner, MD, MSc, Mohammad Zubairi, MD, MEd, Challenging ASD Cases November 11, 2017 Melanie Penner, MD, MSc, FRCPC @drmelpenner Mohammad Zubairi, MD, MEd, FRCPC @md_mszubairi Learning Objectives By the end of this workshop, participants will: 1)

More information

Alpha-2 Agonists. Antipsychotics

Alpha-2 Agonists. Antipsychotics Table 5: Randomized Controlled Trials of Psychotropic Medications in Children and Adolescents with ASD Agent Study Target Symptoms Dose Demographics Significant Side Clonidine Guanfacine Jaselskis et al.,

More information

Pediatric Psychopharmacology

Pediatric Psychopharmacology Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders

More information

Disclosure Statement. A Rational Approach to Psychopharmacology. Goals 10/28/2013

Disclosure Statement. A Rational Approach to Psychopharmacology. Goals 10/28/2013 A Rational Approach to Psychopharmacology Disclosure Statement Full time employed physician with MaineGeneral Medical Center in Waterville and Augusta No conflicts of interest to disclose Goals Promote

More information

Psychiatric Medications. Positive and negative effects in the classroom

Psychiatric Medications. Positive and negative effects in the classroom Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children

More information

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine

More information

11/2/2016 INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM FACULTY DISCLOSURE

11/2/2016 INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM FACULTY DISCLOSURE FACULTY DISCLOSURE INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM KristinDawson, MD Assistant Professor University of Kentucky No commercial conflicts of Interest Salary

More information

Role of ADHD medication in children with autism spectrum disorder. Pieter Hoekstra University of Groningen, Netherlands

Role of ADHD medication in children with autism spectrum disorder. Pieter Hoekstra University of Groningen, Netherlands Role of ADHD medication in children with autism spectrum disorder Pieter Hoekstra University of Groningen, Netherlands Symptoms of ADHD are highly prevalent in children with ASD Two independent chart reviews

More information

Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center

Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center Abstract: The majority of boys and many girls with fragile X

More information

Psychopharmacology of Autism Spectrum Disorder

Psychopharmacology of Autism Spectrum Disorder Psychopharmacology of Autism Spectrum Disorder Christopher J. McDougle, MD Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral Hospital

More information

VI.2 Elements for a public summary. VI.2.1 Overview of disease epidemiology

VI.2 Elements for a public summary. VI.2.1 Overview of disease epidemiology VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology Incidence and prevalence of target indication Schizophrenia is a mental disorder characterized by a breakdown of thought processes

More information

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release

More information

Ohio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for You and Your Family. This is the property of

Ohio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for You and Your Family. This is the property of Minds Matter Ohio Psychotropic Medication Quality Improvement Collaborative Minds Matter Toolkit for You and Your Family This is the property of About Minds Matter Minds Matter is a project to help teens,

More information

Disclosures. Autism Society of Wisconsin. Case 2. Case 1. Case 3. Case 4 3/29/2018. Medication treatment for people with Autism Spectrum Disorder

Disclosures. Autism Society of Wisconsin. Case 2. Case 1. Case 3. Case 4 3/29/2018. Medication treatment for people with Autism Spectrum Disorder Medication treatment for people with Autism Spectrum Disorder Autism Society of Wisconsin April 20, 2018 Richard P. Barthel, M.D. Disclosures In accordance with the ACCME policy on relevant financial disclosure,

More information

Aggression (Severe) in Children under Age 6

Aggression (Severe) in Children under Age 6 Aggression (Severe) in Children under Age 6 Level 0 Comprehensive diagnostic assessments. Refer to Principles of Practice on page 6. Evaluate and treat comorbid conditions (i.e. medical, other psychiatric

More information

Piecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder

Piecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder Piecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder Hannah Sauer, PharmD PGY1 Pediatric Pharmacy Resident Mayo Clinic 2015 MFMER slide-1 Objectives

More information

Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives

Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives Mary Elizabeth Jones, Pharm BSc, RPh Senior Pharmacist AHCA Pharmacy

More information

The Mental Health and Wellbeing of Children and Adolescents who are affected by Autism and Related Disorders

The Mental Health and Wellbeing of Children and Adolescents who are affected by Autism and Related Disorders The Mental Health and Wellbeing of Children and Adolescents who are affected by Autism and Related Disorders Charles Cartwright, M.D Director: YAI Autism Center March 2013 Autism Spectrum Defined by the

More information

11/11/2018. The ABCs of Medication Management for Autism Spectrum Disorder. ABC Logging (FBA) First. ABC Logging HOW TO COMPLEMENT BEHAVIORAL THERAPY

11/11/2018. The ABCs of Medication Management for Autism Spectrum Disorder. ABC Logging (FBA) First. ABC Logging HOW TO COMPLEMENT BEHAVIORAL THERAPY The ABCs of Medication Management for Autism Spectrum Disorder OR HOW TO COMPLEMENT BEHAVIORAL THERAPY ABC Logging (FBA) First We need to know what, when, where and why behaviors happen. Antecedent: What

More information

Things You Might Not Know About Psychotropic Medications But Wish You Did

Things You Might Not Know About Psychotropic Medications But Wish You Did Things You Might Not Know About Psychotropic Medications But Wish You Did John E. Dunne, MD December 3, 2016 PAL Conference Conflicts of Interest None to report I am employed by Seattle Children s and

More information

Treating Disruptive Behavior Disorders in Children and Teens. A Review of the Research for Parents and Caregivers

Treating Disruptive Behavior Disorders in Children and Teens. A Review of the Research for Parents and Caregivers Treating Disruptive Behavior Disorders in Children and Teens A Review of the Research for Parents and Caregivers e Is This Information Right for Me? This information is for you if: A health care professional*

More information

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX A acceptance and commitment therapy Posttraumatic Stress, 69 ADHD Adjunctive Fatty Acids, 5 Adjunctive Guanfacine Pharmacokinetics, 27 Amantadine, 21 Atomoxetine, 23 Cancer Risk, 31 CBT for Comorbid Anxiety,

More information

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic

More information

Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder,

Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder, Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder, Journal of the Academy of Child and Adolescent Psychiatry, 1997 Primary Authors: Jon McClellan MD

More information

Indications for Medications. John Wermager, MD May 2, 2017

Indications for Medications. John Wermager, MD May 2, 2017 Indications for Medications John Wermager, MD May 2, 2017 First and foremost, accurate diagnosis is imperative for good treatment. It may also guide a person to go down the medication route sooner, depending

More information

Autism Spectrum Disorder and Mental Health Challenges in Youth

Autism Spectrum Disorder and Mental Health Challenges in Youth Autism Spectrum Disorder and Mental Health Challenges in Youth Management in the Primary Care Setting February 13, 2016 Rebecca Marshall, MD, MPH Outline DSM V Criteria Comorbidities Behavioral treatments

More information

Using Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal. Alan Poling, Ph.D., BCBA-D Western Michigan University

Using Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal. Alan Poling, Ph.D., BCBA-D Western Michigan University Using Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal Alan Poling, Ph.D., BCBA-D Western Michigan University In a 2010 study of 60,641 children Mandell et al. found that: 56%

More information

ADHD Medications. Medication for ADHD: What you need to know. Are ADHD Drugs Right for You or Your Child?

ADHD Medications. Medication for ADHD: What you need to know. Are ADHD Drugs Right for You or Your Child? ADHD Medications Are ADHD Drugs Right for You or Your Child? Medication can help reduce symptoms of hyperactivity, inattentiveness, and impulsivity in children and adults with ADHD. However, medications

More information

Introduction to Drug Treatment

Introduction to Drug Treatment Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical

More information

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.

More information

Behavioral Health. Behavioral Health. Prescribing Guidelines

Behavioral Health. Behavioral Health. Prescribing Guidelines Behavioral Health Behavioral Health Prescribing Guidelines Attention Deficit/Hyperactivity Disorder (ADHD) Start with a first line medication, either from the methylphenidate or dextroamphetamine-amphetamine

More information

Review family/child history of heart condition* interventions 1

Review family/child history of heart condition* interventions 1 ADHD Psychotherapeutic Trial Methylphenidate/Dexmethylphenidate Parent Behavior Medication can be discontinued quickly Training (PBT) Review family/child history of heart condition* interventions 1 1 /Screening

More information

Medications in Autism: What We Know and Don't Know

Medications in Autism: What We Know and Don't Know Medications in Autism: What We Know and Don't Know Jeremy Veenstra-VanderWeele, M.D. Mortimer D. Sackler, M.D., Associate Professor Center for Autism and the Developing Brain Sackler Institute for Developmental

More information

An Overview on the Use of Psychotropic Medications

An Overview on the Use of Psychotropic Medications An Overview on the Use of Psychotropic Medications Marilyn B. Benoit, M.D. Chief Clinical Officer SVP, Clinical & Professional Affairs Classes of Medications Antidepressants Anti-anxiety Mood stabilizers

More information

Patient/Caregiver Information Brochure For Bipolar I Disorder in Adolescents

Patient/Caregiver Information Brochure For Bipolar I Disorder in Adolescents Patient/Caregiver Information Brochure For Bipolar I Disorder in Adolescents Date of approval: March 2013 Mercury number: 570HQ13NP00107-01-IE 786203127-001_Patient_Caregiver_IRELAND_v4.indd 1 20/03/2013

More information

Treatment Options for Bipolar Disorder Contents

Treatment Options for Bipolar Disorder Contents Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8

More information

How does risperdal work for autism

How does risperdal work for autism How does risperdal work for autism The FDA approved the use of risperidone or Risperdal orally disintegrating tablets for the treatment of. Risperdal as a Treatment for Autism By Vincent. Schizophrenia

More information

RMP version 3.0 Aripiprazole

RMP version 3.0 Aripiprazole VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Schizophrenia The prevalence (proportion of the population found to have a disease) of schizophrenia (a disease characterised

More information

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For

More information

Aripiprazole Accord 5, 10, 15 and 30 mg film-coated tablets

Aripiprazole Accord 5, 10, 15 and 30 mg film-coated tablets Aripiprazole Accord 5, 10, 15 and 30 mg film-coated tablets EDUCATIONAL MATERIAL FOR THE PATIENTS AND THEIR CAREGIVERS Introduction Your doctor has diagnosed you with bipolar I disorder and prescribed

More information

Trouble shooting medication adjustment and side effect management in children with ADHD

Trouble shooting medication adjustment and side effect management in children with ADHD Trouble shooting medication adjustment and side effect management in children with ADHD Drs. Joanna Holland and Sarah Manos 44 th Annual Dalhousie Spring Refresher April 5, 2018 Disclosure We have no disclosures

More information

6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related.

6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related. Autism Spectrum Disorders and Co-existing Mental Health Issues By Dr. Karen Berkman Objective To present an overview of common psychiatric conditions that occur in persons with autism spectrum disorders

More information

Jennifer Zarcone. Kennedy Krieger Institute and Johns Hopkins School of Medicine

Jennifer Zarcone. Kennedy Krieger Institute and Johns Hopkins School of Medicine Jennifer Zarcone Kennedy Krieger Institute and Johns Hopkins School of Medicine 1 2 Estimated that between 20% to 45% of people with autism and ID are taking psychotropic medication 14% 30% are taking

More information

MEDICATION GUIDE. Quetiapine (kwe-tye-a-peen) Tablets USP

MEDICATION GUIDE. Quetiapine (kwe-tye-a-peen) Tablets USP MEDICATION GUIDE Quetiapine (kwe-tye-a-peen) Tablets USP Read this Medication Guide before you start taking quetiapine tablets and each time you get a refill. There may be new information. This information

More information

Elements for a Public Summary

Elements for a Public Summary VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Schizophrenia Schizophrenia is a mental illness with a number of symptoms, including confused or unclear thinking and speech,

More information

2013 Virtual AD/HD Conference 1

2013 Virtual AD/HD Conference 1 Medication for & Coexisting Conditions Part 2 Dr. Kenny Handelman Child, Adolescent & Adult Psychiatrist Halton Healthcare Adjunct Professor of Psychiatry, University of Western Ontario www.drkenny.com

More information

Attention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6

Attention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6 in Children under Age 6 Level 0 Conduct comprehensive assessment and provide psychoeducation about ADHD, including clearly defined treatment expectations. Consider co-morbid developmental language disorder,

More information

D I A G N O S I S ADD/ADHD. Conduct Disorder. Oppositional. Oppositional Defiant Disorder. Defiant. Anxiety Disorder. Adjustment.

D I A G N O S I S ADD/ADHD. Conduct Disorder. Oppositional. Oppositional Defiant Disorder. Defiant. Anxiety Disorder. Adjustment. Dr. Crismon has no potential conflicts of interest to disclose with regard to this presentation. M. Lynn Crismon, Pharm.D., FCCP, BCPP Dean James T. Doluisio Regents Chair & Behrens Centennial Professor

More information

6/20/2014. Medication in SMS: What s the evidence? What s reasonable? Management of Children with Developmental Disorders

6/20/2014. Medication in SMS: What s the evidence? What s reasonable? Management of Children with Developmental Disorders Medication in SMS: What s the evidence? What s reasonable? Tom Challman, MD Medical Director Autism & Developmental Medicine Institute Geisinger Health System Management of Children with Developmental

More information

Atomoxetine. Open study showed 60% response of inattention and hyperactivity with a few much worse (Jou et al 2005)

Atomoxetine. Open study showed 60% response of inattention and hyperactivity with a few much worse (Jou et al 2005) Atomoxetine Open study showed 60% response of inattention and hyperactivity with a few much worse (Jou et al 2005) Buspirone Case reports (McCormick 1997, Hillbrand and Scott 1995,Realmuto et al 1989,

More information

Tools that make a difference in mental health symptoms of autistic spectrum children Sumru Bilge-Johnson M.D. Program Director of Child Psychiatry

Tools that make a difference in mental health symptoms of autistic spectrum children Sumru Bilge-Johnson M.D. Program Director of Child Psychiatry Tools that make a difference in mental health symptoms of autistic spectrum children Sumru Bilge-Johnson M.D. Program Director of Child Psychiatry Fellowship Associate Professor, Child Psychiatry NEOMED

More information

AP PSYCH Unit 13.3 Biomedical Therapies

AP PSYCH Unit 13.3 Biomedical Therapies AP PSYCH Unit 13.3 Biomedical Therapies Prescribed medications or medical procedures that act directly on the patient s nervous system. Drugs that alter brain chemistry Affecting brain circuitry with electric

More information

Paediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK).

Paediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK). Paediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK). Childhood pharmacokinetics Children have greater hepatic capacity More glomerular filtration Less fatty tissue Less ability to store

More information

YOUR GUIDE TO ARIPIPRAZOLE Patient/Caregiver Information Brochure

YOUR GUIDE TO ARIPIPRAZOLE Patient/Caregiver Information Brochure YOUR GUIDE TO ARIPIPRAZOLE Patient/Caregiver Information Brochure Aripiprazole Dr. Reddy's 5, 10, 15 and 30 mg film-coated tablets Aripiprazole Dr. Reddy s 1 mg/ml Oral Solution Introduction Your doctor

More information

Bob Klaehn, M.D. Bob Klaehn, M.D. October 3, /30/14

Bob Klaehn, M.D. Bob Klaehn, M.D. October 3, /30/14 Bob Klaehn, M.D. October 3, 2014 1 Bob Klaehn, M.D. Medical Director, Arizona Division of Developmental Disabilities since 2001 Faculty, MIHS Child Psychiatry Residency Program Child Psychiatrist, District

More information

Pharmacists in Medication Adherence in Psychiatric Patients

Pharmacists in Medication Adherence in Psychiatric Patients Pharmacists in Medication Adherence in Psychiatric Patients Mamta Parikh, PharmD, BCPS, BCPP Assistant Professor, Clinical and Administrative Sciences Notre Dame of Maryland University School of Pharmacy

More information

Medication Audit Checklist- Antipsychotics - Atypical

Medication Audit Checklist- Antipsychotics - Atypical Medication Audit checklist Page 1 of 7 10-2018 Audit number: Client number: Ordering Provider: INDICATIONS 1) Disorders with psychotic symptoms (schizophrenia, schizoaffective disorder, manic disorders,

More information

MEDICATION GUIDE. Aripiprazole Tablets (AR-i-PIP-ra-zole)

MEDICATION GUIDE. Aripiprazole Tablets (AR-i-PIP-ra-zole) MEDICATION GUIDE Aripiprazole Tablets (AR-i-PIP-ra-zole) What is the most important information I should know about aripiprazole tablets? (For other side effects, also see What are the possible side effects

More information

Parents Guide to ADHD Medications. Copyright Child Mind Institute

Parents Guide to ADHD Medications. Copyright Child Mind Institute Copyright 2017. Child Mind Institute Children with attention-deficit hyperactivity disorder (ADHD) find it unusually difficult to concentrate on tasks, to pay attention, to sit still and to control impulsive

More information

Brief Notes on the Mental Health of Children and Adolescents

Brief Notes on the Mental Health of Children and Adolescents Brief Notes on the Mental Health of Children and Adolescents The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems

More information

Evidence-Based Pharmacotherapy. Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center

Evidence-Based Pharmacotherapy. Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center Evidence-Based Pharmacotherapy Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center CME Disclosure I have no personal financial relationships in any commercial interest related to

More information

Autism Spectrum. Mental Health Issues. A guidebook for mental health professionals

Autism Spectrum. Mental Health Issues. A guidebook for mental health professionals Autism Spectrum & Disorder Mental Health Issues A guidebook for mental health professionals Introduction to Autism & Mental Health This guide has been developed to provide mental health professionals with

More information

Autism/Pervasive Developmental Disorders Update. Kimberly Macferran, MD Pediatric Subspecialty for the Primary Care Provider December 2, 2011

Autism/Pervasive Developmental Disorders Update. Kimberly Macferran, MD Pediatric Subspecialty for the Primary Care Provider December 2, 2011 Autism/Pervasive Developmental Disorders Update Kimberly Macferran, MD Pediatric Subspecialty for the Primary Care Provider December 2, 2011 Overview Diagnostic criteria for autism spectrum disorders Screening/referral

More information

Developmental Disorders

Developmental Disorders Pharmacology of Pervasive Developmental Disorders W. David Lohr, M.D. Assistant Professor Child Psychiatry Bingham Child Guidance Center University of Louisville School of Medicine 502-852-1065 wdlohr01@louisville.edu

More information

Schedule FDA & literature based indications

Schedule FDA & literature based indications Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for

More information

3/27/2013. Objectives. Psychopharmacology at the End of Life Nicole Thurston, MD

3/27/2013. Objectives. Psychopharmacology at the End of Life Nicole Thurston, MD Psychopharmacology at the End of Life Nicole Thurston, MD Psychiatrist Mountain States Tumor Institute Objectives Describe 2 common psychiatric symptoms that can present at or near end of life. Review

More information

Pharmacotherapy of psychosis and schizophrenia in youth

Pharmacotherapy of psychosis and schizophrenia in youth Pharmacotherapy of psychosis and schizophrenia in youth Benedetto Vitiello Pavia, 2 December 2017 Disclosure Benedetto Vitiello, M.D. Professor of Child and Adolescent Neuropsychiatry University of Turin,

More information

ADHD Part II: Managing Comorbities

ADHD Part II: Managing Comorbities ADHD Part II: Managing Comorbities Brett Johnson, MD Staff Psychiatrist Rady Children s Behavioral Crisis Center Assistant Clinical Professor (Voluntary), UCSD January 26, 2011 Financial Disclosure I have

More information

Clonidine for mood The Borg System is 100 % Retrievable & Reusable Clonidine for mood

Clonidine for mood The Borg System is 100 % Retrievable & Reusable Clonidine for mood Clonidine for mood The Borg System is 100 % Clonidine for mood 22-5-2014 Clonidine is a drug that is used primarily to treat high blood pressure by acting as an α2 adrenergic agonist. It also has been

More information

ADHD Explanation 5: Medications used in ADHD

ADHD Explanation 5: Medications used in ADHD ADHD Explanation 5: Medications The aim of treatment is efficient functioning and achieving goals in life It is most important to find the dose of medications that works best As children grow they may

More information

MEDICATION GUIDE Quetiapine Fumarate Extended-Release Tablets (Kwe-TYE-a-peen FUE-ma-rate)

MEDICATION GUIDE Quetiapine Fumarate Extended-Release Tablets (Kwe-TYE-a-peen FUE-ma-rate) MEDICATION GUIDE Quetiapine Fumarate Extended-Release Tablets (Kwe-TYE-a-peen FUE-ma-rate) Read this Medication Guide before you start taking quetiapine fumarate extended-release tablets and each time

More information

Pharmacologic Management of ADHD

Pharmacologic Management of ADHD Pharmacologic Management of ADHD CHADD Presentation April 13, 2015 Peter J Chung, MD, FAAP Developmental-Behavioral Pediatrician* Assistant Clinical Professor of Pediatrics University of California Irvine

More information

Understanding the Use of Psychotherapy and Psychotropic Medications for Oppositional Defiance and Conduct Disorders. Prof.

Understanding the Use of Psychotherapy and Psychotropic Medications for Oppositional Defiance and Conduct Disorders. Prof. Understanding the Use of Psychotherapy and Psychotropic Medications for Oppositional Defiance and Conduct s Prof. Daniel Kaplin College of Staten Island One of the new chapters in the Diagnostic and Statistical

More information

(levomilnacipran) extended-release capsules

(levomilnacipran) extended-release capsules MEDICATION GUIDE FETZIMA (fet-zee-muh) (levomilnacipran) extended-release capsules Read this Medication Guide before you start taking FETZIMA and each time you get a refill. There may be new information.

More information

Medication Management in Tic Disorders. Erica Greenberg, MD Pediatric Psychiatry OCD and Tic Disorders Program 7/29/18

Medication Management in Tic Disorders. Erica Greenberg, MD Pediatric Psychiatry OCD and Tic Disorders Program 7/29/18 Medication Management in Tic Disorders Erica Greenberg, MD Pediatric Psychiatry OCD and Tic Disorders Program 7/29/18 Speaker Disclosures: No relevant disclosures (Clinical research study funded in part

More information

TOP APS DRUGS TRAZODONE BRAND NAMES: OLEPTRO, DESYREL (DIVIDOSE) & TRIALODINE

TOP APS DRUGS TRAZODONE BRAND NAMES: OLEPTRO, DESYREL (DIVIDOSE) & TRIALODINE trazodone TOP APS DRUGS TRAZODONE BRAND NAMES: OLEPTRO, DESYREL (DIVIDOSE) & TRIALODINE Pharmacodynamics study of what a drug does to the body Studies show that trazodone selectively inhibits neuronal

More information

Autism Spectrum Disorder: An Update Kathleen A. Koth, D.O.

Autism Spectrum Disorder: An Update Kathleen A. Koth, D.O. Autism Spectrum Disorder: An Update Kathleen A. Koth, D.O. Assistant Professor, Child and Adolescent Psychiatry Program Director, Child and Adolescent Psychiatry Fellowship President, Wisconsin Council

More information

Antidepressants. Dr Malek Zihlif

Antidepressants. Dr Malek Zihlif Antidepressants The optimal use of antidepressant required a clear understanding of their mechanism of action, pharmacokinetics, potential drug interaction and the deferential diagnosis of psychiatric

More information

Asperger s Syndrome. severe difficulties interacting socially (Gillberg 2002). He named this difficulty

Asperger s Syndrome. severe difficulties interacting socially (Gillberg 2002). He named this difficulty Julie Burton 7.16.2012 ED 243 Paper Asperger s Syndrome History In 1944 an Austrian pediatrician named Hans Asperger wrote an article about a group of school- aged boys when he discovered that some of

More information

Professor Tony Holland, Department of Psychiatry, University of Cambridge

Professor Tony Holland, Department of Psychiatry, University of Cambridge INFORMATION SHEET The Use of Medication for Challenging Behaviour Professor Tony Holland, Department of Psychiatry, University of Cambridge Introduction Challenging behaviours displayed by people with

More information

Jean Paul Richter, writer ( )

Jean Paul Richter, writer ( ) The words a father speaks to his children in the privacy of the home are not overheard at the time, but, as in whispering galleries, they will be clearly heard at the end and by posterity. Jean Paul Richter,

More information

PL CE LIVE February 2011 Forum

PL CE LIVE February 2011 Forum February 2011 PL CE LIVE Kristin W. Weitzel, Pharm.D., CDE, FAPhA Associate Editor and Director of Editorial Projects Pharmacist s Letter/Prescriber s Letter Atypical Antipsychotics Atypical Antipsychotics

More information

Venlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including:

Venlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including: Medication Guide VENLAFAXINE XR (venlafaxine hydrochloride) (Extended-Release Capsules) Read the Medication Guide that comes with venlafaxine hydrochloride extended-release before you start taking it and

More information

5/2/2017. By Pamela Pepper PMH, CNS, BC. DSM-5 Growth and Development

5/2/2017. By Pamela Pepper PMH, CNS, BC. DSM-5 Growth and Development By Pamela Pepper PMH, CNS, BC DSM-5 Growth and Development The idea that diagnosis is based on subjective criteria and that those criteria should fall neatly into a set of categories is not sustainable,

More information

Q&A Summary: Autism Spectrum Disorder (ASD) Part II: Medical Home Care for Children With ASD and Other Developmental Disabilities

Q&A Summary: Autism Spectrum Disorder (ASD) Part II: Medical Home Care for Children With ASD and Other Developmental Disabilities Q&A Summary: Autism Spectrum Disorder (ASD) Part II: Medical Home Care for Children With ASD and Other Developmental Disabilities Available On-Demand: optumhealtheducation.com/autism-part-ii-2018 Presenter:

More information

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For

More information

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive

More information

To Give or not to Give Medication: That is the Question

To Give or not to Give Medication: That is the Question To Give or not to Give Medication: That is the Question Charmi Patel Rao, MD September 14, 2018 Introduction Board Certified Child & Adolescent Psychiatrist Clinical expertise in ECMH and Developmental

More information

Taking Care: Child and Youth Mental Health TREATMENT OPTIONS

Taking Care: Child and Youth Mental Health TREATMENT OPTIONS Taking Care: Child and Youth Mental Health TREATMENT OPTIONS Open Learning Agency 2004 TREATMENT OPTIONS With appropriate treatment, more than 80% of people with depression get full relief from their symptoms

More information

File NDA SE5 046/047, NDA SE5 036/037, NDA SE5 020/021

File NDA SE5 046/047, NDA SE5 036/037, NDA SE5 020/021 M E M O R A N D U M DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH DATE: 18 June 2007 FROM: TO: SUBJECT: Mitchell V.

More information

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder

More information

Mental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling

Mental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Mental Illness Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Moodiness Changing Bodies Narcissism Self-Esteem Ignorant Naïve Insecure Self-Centered Independent Adolescence Disorders Affecting

More information

Psychotropic Drug Therapy in Adults with Learning Disability. Steve Wilkinson

Psychotropic Drug Therapy in Adults with Learning Disability. Steve Wilkinson Psychotropic Drug Therapy in Adults with Learning Disability Steve Wilkinson Outline and Aims of the Session Drug use in learning disability Two distinct areas of drug therapy I. Treatment of common psychiatric

More information

Treatment of Autism Spectrum Disorder in Children and Adolescents

Treatment of Autism Spectrum Disorder in Children and Adolescents Evidence-Based Medicine Key Words: autism spectrum disorder, treatment, psychotherapy, psychopharmacology Treatment of Autism Spectrum Disorder in Children and Adolescents By Melissa DeFilippis, Karen

More information